Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (s)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol
2. 2-propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (s)-
3. Blocadren
4. L 714,465
5. L-714,465
6. L714,465
7. Mk 950
8. Mk-950
9. Mk950
10. Optimol
11. Timacar
12. Timolol
13. Timolol Hemihydrate
14. Timolol Maleate, (1:1) Salt
15. Timoptic
16. Timoptol
1. 26921-17-5
2. (s)-timolol Maleate
3. Timolol Maleate Salt
4. Blocadren
5. Timoptic
6. Timolol Hydrogen Maleate
7. Istalol
8. (s)-timolol (maleate)
9. (s)-timolol Hydrogen Maleate
10. Timoptic-xe
11. Ophtamolol
12. Aquanil
13. Mk 950
14. Timolol (as Maleate)
15. Timolol Hydrogen Maleate Salt
16. Timolol Maleate, S-enantiomer
17. Wp-934
18. Mls000028539
19. Chebi:9600
20. 60469-65-0
21. P8y54f701r
22. (-)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol Maleate
23. Nsc-757351
24. (-)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol Maleate (1:1) (salt)
25. (z)-but-2-enedioic Acid;(2s)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
26. 2-propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (s)-, (z)-2-butenedioate (1:1) (salt)
27. Smr000058305
28. Timacor
29. Betime
30. L-timolol Maleate
31. Timoptic In Ocudose
32. Mfcd00058356
33. 2-propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2s)-, (2z)-2-butenedioate (salt)
34. Ccris 1057
35. Einecs 248-111-5
36. Cas-26921-17-5
37. (s)-(-)-timolol Maleate
38. Timololmaleate
39. Timololi Maleas
40. Unii-p8y54f701r
41. S-timolol Maleate
42. Blocadren (tn)
43. Timolol Maleate [usan:usp:jan]
44. Timoptic (tn)
45. Einecs 262-251-4
46. Istalol (tn)
47. Bimatoprost / Timolol
48. Timolol Hydrogenmaleate
49. Opera_id_1256
50. Dsstox_cid_27504
51. Dsstox_rid_82384
52. Dsstox_gsid_47504
53. Schembl26233
54. Mls001076135
55. Timolol Maleate [jan]
56. Timolol Maleate (jp17/usp)
57. Timolol Maleate [usan]
58. L-714,465 (maleate)
59. Timolol Maleate [vandf]
60. Chembl1200870
61. Dtxsid3047504
62. Timolol Maleate [mart.]
63. Timolol Maleate [usp-rs]
64. Timolol Maleate [who-dd]
65. Timolol Maleate [who-ip]
66. Hms1570n18
67. Hms2097n18
68. Hms2230n19
69. Hms2234f03
70. Hms3411m12
71. Hms3675m12
72. Hms3714n18
73. Hms3885l05
74. Tox21_302468
75. S4123
76. Timolol Maleate [orange Book]
77. Akos024458595
78. Timolol Maleate [ep Monograph]
79. Timolol Maleate [usp Impurity]
80. Ccg-220948
81. Cosopt Component Timolol Maleate
82. Cs-1028
83. Nsc 757351
84. Timolol Maleate [usp Monograph]
85. Timololi Maleas [who-ip Latin]
86. (s)-3-(3-(tert-butylamino)-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole Maleate
87. Duotrav Component Timolol Maleate
88. Ganfort Component Timolol Maleate
89. Xalacom Component Timolol Maleate
90. Combigan Component Timolol Maleate
91. Ncgc00256737-01
92. 2-propanol, 1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-, (-)-, Maleate (1:1) (salt)
93. 2-propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2s)-, (2z)-2-butenedioate (1:1) (salt)
94. As-18090
95. Bs164420
96. Hy-17380
97. Smr000653470
98. Timolol Hydrogen Maleate Salt [mi]
99. Timolol Maleate Component Of Cosopt
100. Timolol Maleate Component Of Duotrav
101. Timolol Maleate Component Of Ganfort
102. T2905
103. Timolol Maleate Component Of Combigan
104. Timolol Maleate Salt, >=98% (tlc), Powder
105. A13429
106. D00603
107. F20622
108. Timolol Maleate, S-enantiomer [who-dd]
109. 921t175
110. Sr-01000003102
111. Q-201836
112. Sr-01000003102-3
113. Q27108445
114. Timolol Maleate 1.0 Mg/ml In Methanol (as Free Base)
115. Timolol Maleate, British Pharmacopoeia (bp) Reference Standard
116. Timolol Maleate, European Pharmacopoeia (ep) Reference Standard
117. Timolol Maleate, United States Pharmacopeia (usp) Reference Standard
118. (s)-1-tert-butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol Maleate
119. 1-( Tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol Maleate
120. Timolol For System Suitability, European Pharmacopoeia (ep) Reference Standard
121. (2s)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol (2z)-but-2-enedioate
122. (s)-1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol Maleate
Molecular Weight | 432.5 g/mol |
---|---|
Molecular Formula | C17H28N4O7S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 9 |
Exact Mass | 432.16787042 g/mol |
Monoisotopic Mass | 432.16787042 g/mol |
Topological Polar Surface Area | 183 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 429 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 8 | |
---|---|
Drug Name | Timoptic-xe |
Drug Label | TIMOPTIC-XE (timolol maleate ophthalmic solution) is a non-selective beta-adrenergic receptor blocking agent. Its chemical name is (-)-1-(tert-butylamino)-3- [(4-morpholino-1, 2, 5-thiadiazol-3-yl)oxy]-2-propanol maleate (1:1) (salt). Timolol malea... |
Active Ingredient | Timolol maleate |
Dosage Form | Solution, gel forming/drops |
Route | Ophthalmic |
Strength | eq 0.25% base; eq 0.5% base |
Market Status | Prescription |
Company | Valeant Pharms |
2 of 8 | |
---|---|
Drug Name | Timolol maleate |
Active Ingredient | Timolol maleate |
Dosage Form | Solution/drops; Tablet; Solution, gel forming/drops |
Route | Ophthalmic; Oral |
Strength | eq 0.25% base; 5mg; 10mg; eq 0.5% base; 20mg |
Market Status | Prescription |
Company | Wockhardt; Falcon Pharms; Pacific Pharma; Hi Tech Pharma; Bausch And Lomb; Fdc; Mylan; Akorn |
3 of 8 | |
---|---|
Drug Name | Timoptic |
Drug Label | Timolol Maleate Ophthalmic Gel Forming Solution is a non-selective beta-adrenergic receptor blocking agent. Its chemical name is (-)-1-(tert-butylamino)-3- [(4-morpholino-1, 2, 5-thiadiazol-3-yl)oxy]-2-propanol maleate (1:1) (salt). Timolol maleate p... |
Active Ingredient | Timolol maleate |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.25% base; eq 0.5% base |
Market Status | Prescription |
Company | Aton |
4 of 8 | |
---|---|
Drug Name | Timoptic in ocudose |
PubMed Health | Timolol (Into the eye) |
Drug Classes | Antiglaucoma |
Drug Label | TIMOPTIC-XE (timolol maleate ophthalmic solution) is a non-selective beta-adrenergic receptor blocking agent. Its chemical name is (-)-1-(tert-butylamino)-3- [(4-morpholino-1, 2, 5-thiadiazol-3-yl)oxy]-2-propanol maleate (1:1) (salt). Timolol malea... |
Active Ingredient | Timolol maleate |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.25% base; eq 0.5% base |
Market Status | Prescription |
Company | Aton |
5 of 8 | |
---|---|
Drug Name | Timoptic-xe |
Drug Label | TIMOPTIC-XE (timolol maleate ophthalmic solution) is a non-selective beta-adrenergic receptor blocking agent. Its chemical name is (-)-1-(tert-butylamino)-3- [(4-morpholino-1, 2, 5-thiadiazol-3-yl)oxy]-2-propanol maleate (1:1) (salt). Timolol malea... |
Active Ingredient | Timolol maleate |
Dosage Form | Solution, gel forming/drops |
Route | Ophthalmic |
Strength | eq 0.25% base; eq 0.5% base |
Market Status | Prescription |
Company | Valeant Pharms |
6 of 8 | |
---|---|
Drug Name | Timolol maleate |
Active Ingredient | Timolol maleate |
Dosage Form | Solution/drops; Tablet; Solution, gel forming/drops |
Route | Ophthalmic; Oral |
Strength | eq 0.25% base; 5mg; 10mg; eq 0.5% base; 20mg |
Market Status | Prescription |
Company | Wockhardt; Falcon Pharms; Pacific Pharma; Hi Tech Pharma; Bausch And Lomb; Fdc; Mylan; Akorn |
7 of 8 | |
---|---|
Drug Name | Timoptic |
Drug Label | Timolol Maleate Ophthalmic Gel Forming Solution is a non-selective beta-adrenergic receptor blocking agent. Its chemical name is (-)-1-(tert-butylamino)-3- [(4-morpholino-1, 2, 5-thiadiazol-3-yl)oxy]-2-propanol maleate (1:1) (salt). Timolol maleate p... |
Active Ingredient | Timolol maleate |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.25% base; eq 0.5% base |
Market Status | Prescription |
Company | Aton |
8 of 8 | |
---|---|
Drug Name | Timoptic in ocudose |
PubMed Health | Timolol (Into the eye) |
Drug Classes | Antiglaucoma |
Drug Label | TIMOPTIC-XE (timolol maleate ophthalmic solution) is a non-selective beta-adrenergic receptor blocking agent. Its chemical name is (-)-1-(tert-butylamino)-3- [(4-morpholino-1, 2, 5-thiadiazol-3-yl)oxy]-2-propanol maleate (1:1) (salt). Timolol malea... |
Active Ingredient | Timolol maleate |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.25% base; eq 0.5% base |
Market Status | Prescription |
Company | Aton |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.
Date of Issue : 2022-08-07
Valid Till : 2024-04-11
Written Confirmation Number : WC-0432n
Address of the Firm :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Registration Number : 306MF10098
Registrant's Address : 21,chemin de la Sauvegarde 21 Ecully Parc - CS 33167 69134 Ecully Cedex France
Initial Date of Registration : 2024-07-17
Latest Date of Registration :
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6983
Submission : 1987-05-22
Status : Active
Type : II
Certificate Number : CEP 2014-300 - Rev 01
Issue Date : 2023-09-27
Type : Chemical
Substance Number : 572
Status : Valid
Registration Number : 219MF10315
Registrant's Address : 21,chemin de la Sauvegarde 21 Ecully Parc - CS 33167 69134 Ecully Cedex France
Initial Date of Registration : 2007-10-24
Latest Date of Registration :
NDC Package Code : 51014-7125
Start Marketing Date : 2015-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, CA |
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6983
Submission : 1987-05-22
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-27
Pay. Date : 2017-01-23
DMF Number : 29342
Submission : 2015-07-07
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-31
Pay. Date : 2012-12-20
DMF Number : 10690
Submission : 1994-01-25
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-26
Pay. Date : 2012-11-13
DMF Number : 7264
Submission : 1987-12-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-10-25
Pay. Date : 2012-11-27
DMF Number : 9839
Submission : 1992-07-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-16
Pay. Date : 2014-06-09
DMF Number : 6644
Submission : 1986-09-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14750
Submission : 2000-02-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8226
Submission : 1989-09-29
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10900
Submission : 1994-05-12
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8649
Submission : 1990-07-09
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Certificate Number : CEP 1996-049 - Rev 07
Status : Valid
Issue Date : 2023-10-16
Type : Chemical
Substance Number : 572
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Certificate Number : CEP 2014-300 - Rev 01
Status : Valid
Issue Date : 2023-09-27
Type : Chemical
Substance Number : 572
Certificate Number : CEP 2010-084 - Rev 03
Status : Valid
Issue Date : 2023-10-19
Type : Chemical
Substance Number : 572
Certificate Number : CEP 2021-304 - Rev 00
Status : Valid
Issue Date : 2024-04-24
Type : Chemical
Substance Number : 572
Certificate Number : R1-CEP 2001-296 - Rev 05
Status : Valid
Issue Date : 2023-07-05
Type : Chemical
Substance Number : 572
Certificate Number : R1-CEP 2003-070 - Rev 03
Status : Valid
Issue Date : 2020-09-15
Type : Chemical
Substance Number : 572
Certificate Number : R0-CEP 2022-322 - Rev 00
Status : Valid
Issue Date : 2023-06-28
Type : Chemical
Substance Number : 572
Certificate Number : R1-CEP 2003-239 - Rev 05
Status : Valid
Issue Date : 2021-03-16
Type : Chemical
Substance Number : 572
Certificate Number : R1-CEP 2005-065 - Rev 00
Status : Valid
Issue Date : 2012-05-24
Type : Chemical
Substance Number : 572
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 1998-147 - Rev 12
Status : Valid
Issue Date : 2025-03-04
Type : Chemical
Substance Number : 572
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Registration Number : 306MF10098
Registrant's Address : 21,chemin de la Sauvegarde 21 Ecully Parc - CS 33167 69134 Ecully Cedex France
Initial Date of Registration : 2024-07-17
Latest Date of Registration : 2024-07-17
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Timolol maleate (for manufacturing purposes only)
Registration Number : 219MF10315
Registrant's Address : 21,chemin de la Sauvegarde 21 Ecully Parc - CS 33167 69134 Ecully Cedex France
Initial Date of Registration : 2007-10-24
Latest Date of Registration : 2022-08-10
Registration Number : 219MF10207
Registrant's Address : NUERNBERGER STRASSE 12, 90537 FEUCHT, GERMANY
Initial Date of Registration : 2007-06-13
Latest Date of Registration : 2019-07-31
Registration Number : 230MF10162
Registrant's Address : Zone Industrielle de Blavozy 928 Avenue Lavoisier 43700 Saint-Germain-Laprade, France
Initial Date of Registration : 2018-12-03
Latest Date of Registration : 2018-12-03
Registration Number : 227MF10140
Registrant's Address : 142-48,s,v,road,jogeshwari(w),mumbai-400 102 India
Initial Date of Registration : 2015-05-14
Latest Date of Registration : 2015-05-14
Registration Number : 227MF10245
Registrant's Address : Piazzale Luigi Cadorna, 4-20123 MILANO, Italy
Initial Date of Registration : 2015-10-08
Latest Date of Registration : 2015-10-08
Registration Number : 225MF10066
Registrant's Address : No. 168 Kai-Yuan Rd. , Hsin-Ying Tainan City, 73055. Taiwan
Initial Date of Registration : 2013-03-27
Latest Date of Registration : 2016-12-26
Date of Issue : 2022-08-07
Valid Till : 2024-04-11
Written Confirmation Number : WC-0432n
Address of the Firm : Plot No N-5, MIDC, Boisar, Tal Palghar, Dist- Thane, 401506, Maharashtra, India
Date of Issue : 2025-08-19
Valid Till : 2028-06-25
Written Confirmation Number : WC-0107
Address of the Firm : Plot No. 75/76, 76/1 & 74, Chikhloli MIDC, Ambernath (West), Thane- 421501, Maha...
Timolol Maleate USP/BP/Ph.Eur./ IP/JP
Date of Issue : 2025-08-08
Valid Till : 2028-07-07
Written Confirmation Number : WC-0055
Address of the Firm : Plot No. 19 & 20/2, MIDC, Dhatav, Taluka: Roha, District-Raigad, Maharashtra, In...
Date of Issue : 2022-06-08
Valid Till : 2024-04-11
Written Confirmation Number : WC-0432A2
Address of the Firm : Plot No N-5, MIDC, Boisar, Tal Palghar, Dist- Thane, 401506, Maharashtra, India
Date of Issue : 2025-07-22
Valid Till : 2028-07-07
Written Confirmation Number : WC-0104
Address of the Firm : 124, 125 and 126, SIPCOT Industrial Complex, Hosur -635126, Tamil Nadu, India
Date of Issue : 2022-08-11
Valid Till : 2025-08-15
Written Confirmation Number : WC-0225
Address of the Firm : Plot No. 43 to 45, KIADB, Bommasandra Industrial area, 4th phase, Anekal taluk, ...
Date of Issue : 2022-07-27
Valid Till : 2025-07-26
Written Confirmation Number : WC-0531
Address of the Firm : Plot No. D-90/3 TTC IND Area, MIDC Turbhe, Navi Mumbai- 400705,Taluka: Pawvane, ...
Timolol Maleate BP/IP/USP/Ph.Eur
Date of Issue : 2025-06-13
Valid Till : 2028-07-02
Written Confirmation Number : WC-0209
Address of the Firm : Plot No. 2903, 05, 07, 09, 10, 2704 to 2708, GIDC Industrial Estate, Village -Sa...
Registrant Name : Hanlim Pharmaceutical Co., Ltd.
Registration Date : 2013-03-22
Registration Number : 20130121-201-I-134-05(1)
Manufacturer Name : Centaur Pharmaceuticals Priv...
Manufacturer Address : Plot no. 75, 76, 76/1 & 74, Chikhloli MIDC, Ambernath (West), Thane 421 501, Maharash...
Registrant Name : Huons Co., Ltd.
Registration Date : 2014-01-08
Registration Number : 20130121-201-I-134-05(4)
Manufacturer Name : Centaur Pharmaceuticals Priv...
Manufacturer Address : Plot no. 75, 76, 76/1 & 74, Chikhloli MIDC, Ambernath (West), Thane 421 501, Maharash...
Registrant Name : Seongwoo Chemical Co., Ltd.
Registration Date : 2020-03-26
Registration Number : 20130121-201-I-134-05(5)
Manufacturer Name : Centaur Pharmaceuticals Priv...
Manufacturer Address : Plot no. 75, 76, 76/1 & 74, Chikhloli MIDC, Ambernath (West), Thane 421 501, Maharash...
Registrant Name : Samchundang Pharmaceutical Co., Ltd.
Registration Date : 2013-03-22
Registration Number : 20130121-201-I-134-05(2)
Manufacturer Name : Centaur Pharmaceuticals Priv...
Manufacturer Address : Plot no. 75/76, Chikhloli MIDC, Ambernath(W), Thane-421 501, Maharashtra, India
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2013-11-19
Registration Number : 20131119-201-I-286-08
Manufacturer Name : FDC Limited
Manufacturer Address : Plot No. 19 & 20/2, MIDC, Roha Industrial Area, Village Dhatav, Roha-402 116, Dist.- ...
Registrant Name : Taejun Pharmaceutical Co., Ltd.
Registration Date : 2013-08-01
Registration Number : 20130515-201-I-174-07(1)
Manufacturer Name : Olon SPA
Manufacturer Address : Casaletto Lodigiano (LO) - Via Livelli, 1 - Fraz. Mairano, Italy.
Registrant Name : Bashu Health Korea Co., Ltd.
Registration Date : 2013-05-15
Registration Number : 20130515-201-I-174-07
Manufacturer Name : Olon SPA
Manufacturer Address : Casaletto Lodigiano (LO) - Via Livelli, 1 - Fraz. Mairano, Italy.
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2014-09-29
Registration Number : 20140929-201-I-404-09
Manufacturer Name : Sicor Societa' Italiana Cort...
Manufacturer Address : Bulciago(LC)-Strada Briantea KM 36, 83, Italy _x000D_
Registrant Name : Novartis Korea Co., Ltd.
Registration Date : 2015-05-29
Registration Number : 20140929-201-I-404-09(2)
Manufacturer Name : Sicor Societa' Italiana Cort...
Manufacturer Address : Bulciago(LC)-Strada Briantea KM 36, 83, Italy
Registrant Name : Jeil Pharmaceutical Co., Ltd.
Registration Date : 2015-05-12
Registration Number : 20140929-201-I-404-09(1)
Manufacturer Name : SICOR-Societa Italiana Corti...
Manufacturer Address : Bulciago(LC)-Strada Briantea KM 36, 83, Italy
Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.
About the Company : Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian company that specializes in manufacturing APIs and intermediates. Besides being approved by the FDA of India, Bhavna ha...
About the Company : Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations!
The building of a "best-in-class" solution provider starts wit...
About the Company : Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
About the Company : Founded in 1987, Transo-Pharm is a fully licensed and certified global distributor of pharmaceutical components for the health and veterinary industries. The company supports its c...
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
About the Company : Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceutical products to Japan. In 2006, it acquired Pharmasynthèse. Today, Inabata...
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
About the Company : Since its inception in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. With a strong focus on customer support, Seqens assists ...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer of Bulk drugs & Intermediate and also supplies our associate manufacturing plant API / Semi finish form...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
19
PharmaCompass offers a list of Timolol Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Timolol Maleate manufacturer or Timolol Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Timolol Maleate manufacturer or Timolol Maleate supplier.
PharmaCompass also assists you with knowing the Timolol Maleate API Price utilized in the formulation of products. Timolol Maleate API Price is not always fixed or binding as the Timolol Maleate Price is obtained through a variety of data sources. The Timolol Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bimatoprost / timolol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bimatoprost / timolol, including repackagers and relabelers. The FDA regulates Bimatoprost / timolol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bimatoprost / timolol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bimatoprost / timolol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bimatoprost / timolol supplier is an individual or a company that provides Bimatoprost / timolol active pharmaceutical ingredient (API) or Bimatoprost / timolol finished formulations upon request. The Bimatoprost / timolol suppliers may include Bimatoprost / timolol API manufacturers, exporters, distributors and traders.
click here to find a list of Bimatoprost / timolol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bimatoprost / timolol DMF (Drug Master File) is a document detailing the whole manufacturing process of Bimatoprost / timolol active pharmaceutical ingredient (API) in detail. Different forms of Bimatoprost / timolol DMFs exist exist since differing nations have different regulations, such as Bimatoprost / timolol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bimatoprost / timolol DMF submitted to regulatory agencies in the US is known as a USDMF. Bimatoprost / timolol USDMF includes data on Bimatoprost / timolol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bimatoprost / timolol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bimatoprost / timolol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bimatoprost / timolol Drug Master File in Japan (Bimatoprost / timolol JDMF) empowers Bimatoprost / timolol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bimatoprost / timolol JDMF during the approval evaluation for pharmaceutical products. At the time of Bimatoprost / timolol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bimatoprost / timolol suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bimatoprost / timolol Drug Master File in Korea (Bimatoprost / timolol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bimatoprost / timolol. The MFDS reviews the Bimatoprost / timolol KDMF as part of the drug registration process and uses the information provided in the Bimatoprost / timolol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bimatoprost / timolol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bimatoprost / timolol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bimatoprost / timolol suppliers with KDMF on PharmaCompass.
A Bimatoprost / timolol CEP of the European Pharmacopoeia monograph is often referred to as a Bimatoprost / timolol Certificate of Suitability (COS). The purpose of a Bimatoprost / timolol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bimatoprost / timolol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bimatoprost / timolol to their clients by showing that a Bimatoprost / timolol CEP has been issued for it. The manufacturer submits a Bimatoprost / timolol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bimatoprost / timolol CEP holder for the record. Additionally, the data presented in the Bimatoprost / timolol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bimatoprost / timolol DMF.
A Bimatoprost / timolol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bimatoprost / timolol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bimatoprost / timolol suppliers with CEP (COS) on PharmaCompass.
A Bimatoprost / timolol written confirmation (Bimatoprost / timolol WC) is an official document issued by a regulatory agency to a Bimatoprost / timolol manufacturer, verifying that the manufacturing facility of a Bimatoprost / timolol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bimatoprost / timolol APIs or Bimatoprost / timolol finished pharmaceutical products to another nation, regulatory agencies frequently require a Bimatoprost / timolol WC (written confirmation) as part of the regulatory process.
click here to find a list of Bimatoprost / timolol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bimatoprost / timolol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bimatoprost / timolol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bimatoprost / timolol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bimatoprost / timolol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bimatoprost / timolol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bimatoprost / timolol suppliers with NDC on PharmaCompass.
Bimatoprost / timolol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bimatoprost / timolol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bimatoprost / timolol GMP manufacturer or Bimatoprost / timolol GMP API supplier for your needs.
A Bimatoprost / timolol CoA (Certificate of Analysis) is a formal document that attests to Bimatoprost / timolol's compliance with Bimatoprost / timolol specifications and serves as a tool for batch-level quality control.
Bimatoprost / timolol CoA mostly includes findings from lab analyses of a specific batch. For each Bimatoprost / timolol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bimatoprost / timolol may be tested according to a variety of international standards, such as European Pharmacopoeia (Bimatoprost / timolol EP), Bimatoprost / timolol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bimatoprost / timolol USP).